Skip to content
Company Analysis

Shuttle Pharmaceuticals Holding SHPH

A comprehensive view of key metrics, scores, and financial health for Shuttle Pharmaceuticals Holding

Overview of Shuttle Pharmaceuticals Holdings, Inc.

SHPH NCM
Healthcare Drug Manufacturers - Specialty & Generic Micro Cap
Shuttle Pharmaceuticals Holdings, Inc. (SHPH), is a Micro Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $1.05, about 0.0% overvalued vs fair value, -85.3% 1Y return, ranked 1002/1121 in sector.
$1.05
0.00%
As of April 28, 2026
Previous close • Vol 90d: 150.4%
52-Week Range
Market Cap
$5.87M
Enterprise Value
$4.44M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 70%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.shuttlepharma.com
HQ Gaithersburg, MD
Employees 9
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
Gross Profit
$-5.5K
19.8%%
R&D Expense
$3.6M
2.9%%
Operating Income (EBIT)
$-7.8M
-94.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$402.1K

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Shuttle Pharmaceuticals Holding's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
19
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
0
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 43% Coverage
Trade-Off Triangle Visualization A ternary plot showing SHPH's balance between Growth (40.2%), Profitability (5.1%), and Safety (54.8%). Growth 40% Safety 55% Profitability 5%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

- vs peers
-
Key Signals
EPS Growth YoY 10.3% 42p
Strengths
  • D/E Ratio in top 20% of peers (1.65, 90th percentile)
  • Conservative leverage compared to industry peers
Risks

No significant risks identified for this axis.

Profitability

4th percentile vs peers
4
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

45th percentile vs peers
45
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Shuttle Pharmaceuticals Holding.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info